| Recruiting | A Study of Replagal in Children and Adults With Fabry Disease in India Fabry Disease | Phase 4 | 2022-11-01 |
| Withdrawn | A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic Hypoparathyroidism Chronic Hypoparathyroidism | Phase 3 | 2022-08-31 |
| Terminated | A Study of Replagal in Treatment-naïve Adults With Fabry Disease Fabry Disease | Phase 3 | 2021-12-28 |
| Completed | Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India Gaucher Disease | — | 2021-07-28 |
| Withdrawn | ARALAST NP Alpha-1 Lung Density Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) Study Chronic Obstructive Pulmonary Disease, Alpha1-antitrypsin Deficiency | Phase 4 | 2021-03-08 |
| Completed | Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Ou Primary Immunodeficiencies (PID) | — | 2021-02-08 |
| Completed | A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic A Angioedema | Phase 3 | 2021-02-05 |
| Completed | A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Healthy Volunteers | Phase 1 | 2021-01-13 |
| Withdrawn | Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia COVID-19 Pneumonia | Phase 1 | 2020-10-31 |
| Completed | A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administ Healthy Volunteers | Phase 1 | 2020-08-07 |
| Completed | Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE) Hereditary Angioedema (HAE) | Phase 3 | 2019-12-12 |
| Completed | A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II Hereditary Angioedema (HAE) | — | 2019-12-11 |
| Terminated | A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Healthy Volunteers | Phase 1 | 2019-10-25 |
| Completed | A Study of SHP655 (rADAMTS13) in Sickle Cell Disease Sickle Cell Disease | Phase 1 | 2019-10-21 |
| Completed | Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpur Acquired Thrombotic Thrombocytopenic Purpura (aTTP) | Phase 2 | 2019-10-09 |
| Terminated | A Study of VPRIV in Participants With Gaucher Disease Previously Treated With Other Enzyme Replacement Therapi Gaucher Disease | — | 2019-09-19 |
| Completed | A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD) Attention Deficit Hyperactivity Disorder | Phase 4 | 2019-09-18 |
| Completed | A Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Children Hereditary Angioedema | Phase 3 | 2019-08-19 |
| Completed | Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder Binge-eating Disorder | — | 2019-06-01 |
| Completed | A Study to Determine the Bioavailability of Lanadelumab (SHP643) Administered Subcutaneously With the Prefille Healthy Volunteers | Phase 1 | 2019-05-14 |
| Active Not Recruiting | A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy Metachromatic Leukodystrophy (MLD) | Phase 2 | 2019-05-13 |
| Completed | A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America Hereditary Angioedema (HAE) | — | 2019-03-30 |
| Completed | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending, Subcutaneous, Single and Multip Healthy Volunteers | Phase 1 | 2019-03-26 |
| Completed | Drug Use Study With Intuniv® in Australia Attention Deficit Hyperactivity Disorder (ADHD) | — | 2019-03-11 |
| Completed | Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of SPD422 (Anagrelide Hydrochloride) in Hea Healthy Volunteers | Phase 1 | 2019-02-26 |
| Terminated | Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Croh Crohn's Disease | Phase 3 | 2019-02-06 |
| Completed | FIRAZYR General Drug Use-Results Survey (Japan) Hereditary Angioedema (HAE) | — | 2018-11-20 |
| Completed | Drug Use Study With Intuniv® in European Countries Attention Deficit Hyperactivity Disorder (ADHD) | — | 2018-11-15 |
| Terminated | Safety and Efficacy Study of rhPTH(1-84) in Subjects With Hypoparathyroidism Hypoparathyroidism | Phase 3 | 2018-09-26 |
| Completed | Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Sy Short Bowel Syndrome | Phase 3 | 2018-08-31 |
| Terminated | Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Crohn's Disease | Phase 3 | 2018-08-29 |
| Terminated | Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Crohn's Disease | Phase 3 | 2018-07-17 |
| Completed | Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Short Bowel Syndrome | Phase 3 | 2018-07-06 |
| Completed | Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epileptic Nervous System Diseases | Phase 3 | 2018-04-23 |
| Completed | An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulc Ulcerative Colitis | Phase 3 | 2018-04-04 |
| Completed | Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyper Attention Deficit Hyperactivity Disorder (ADHD) | Phase 1 | 2018-03-13 |
| Completed | A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Crohn's Disease, Ulcerative Colitis | Phase 3 | 2018-02-27 |
| Terminated | Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Co Ulcerative Colitis | Phase 3 | 2018-02-09 |
| Completed | A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Con Hypoparathyroidism | Phase 4 | 2018-01-24 |
| Completed | Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701) Hunter Syndrome | — | 2018-01-19 |
| Completed | Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult Subjects Healthy Volunteers | Phase 1 | 2018-01-15 |
| Terminated | Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hypera Attention Deficit Hyperactivity Disorder (ADHD) | Phase 3 | 2018-01-02 |
| Completed | Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) i Attention Deficit Hyperactivity Disorder (ADHD) | Phase 3 | 2017-12-09 |
| Terminated | Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Co Ulcerative Colitis | Phase 3 | 2017-12-05 |
| Completed | Open-label Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Children With Status Epilepti Nervous System Diseases | Phase 3 | 2017-10-23 |
| Terminated | Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophil Eosinophilic Esophagitis (EoE) | Phase 3 | 2017-10-05 |
| Completed | Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder ( Attention Deficit Hyperactivity Disorder (ADHD) | Phase 3 | 2017-09-06 |
| Completed | A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302 Short Bowel Syndrome | Phase 3 | 2017-08-23 |
| Completed | Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects Hypoparathyroidism | Phase 1 | 2017-05-16 |
| Completed | Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma Primary Open-angle Glaucoma (POAG), Ocular Hypertension | Phase 1 | 2017-05-10 |
| Completed | A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Receive Cytomegalovirus (CMV) | Phase 3 | 2017-04-14 |
| Completed | Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) W Hypoparathyroidism | Phase 1 | 2017-04-03 |
| Completed | Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo Bacterial Conjunctivitis | Phase 3 | 2017-03-29 |
| Terminated | Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo Adenoviral Conjunctivitis | Phase 3 | 2017-03-28 |
| Terminated | Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo Adenoviral Conjunctivitis | Phase 3 | 2017-03-27 |
| Terminated | Observational Natural History Study of Autosomal Dominant Retinitis Pigmentosa (adRP) Retinitis Pigmentosa | — | 2017-03-13 |
| Completed | Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support Short Bowel Syndrome | Phase 3 | 2017-01-13 |
| Completed | Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS) Short Bowel Syndrome | Phase 3 | 2017-01-09 |
| Completed | Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Rec Cytomegalovirus (CMV) | Phase 3 | 2016-12-22 |
| Completed | Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 S Short Bowel Syndrome | Phase 3 | 2016-12-09 |
| Completed | A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism Chronic Hypoparathyroidism, Hypoparathyroidism | Phase 4 | 2016-10-27 |
| Completed | Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks i Hereditary Angioedema (HAE) | Phase 3 | 2016-09-08 |
| Completed | THIN Database Study: Resource Use and Outcomes in Patients With Adrenal Insufficiency Prescribed Hydrocortison Adrenal Insufficiency | — | 2016-09-01 |
| Completed | Study of SHP620 (Maribavir) in Healthy Adults Cytomegalovirus (CMV) | Phase 1 | 2016-07-21 |
| Completed | Study of the Effect of Velaglucerase Alfa (VPRIV®) on Bone-related Pathology in Treatment-naïve Participants W Gaucher Disease | Phase 4 | 2016-06-29 |
| Completed | Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition Short Bowel Syndrome | Phase 3 | 2016-06-23 |
| Completed | Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With T Hereditary Angioedema (HAE) | Phase 3 | 2016-05-26 |
| Terminated | A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediat Acute Antibody-Mediated Rejection (AMR) | Phase 3 | 2016-05-20 |
| Completed | An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspe Eosinophilic Esophagitis (EoE) | Phase 3 | 2016-04-01 |
| Completed | Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II H Hereditary Angioedema (HAE) | Phase 3 | 2016-03-03 |
| Completed | Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibi Hereditary Angioedema (HAE) | Phase 1 | 2016-02-19 |
| Completed | A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determ Eosinophilic Esophagitis (EoE) | Phase 3 | 2015-12-07 |
| Completed | Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder Attention Deficit Hyperactivity Disorder (ADHD) | Phase 3 | 2015-11-19 |
| Terminated | Natural History Study of Children With Metachromatic Leukodystrophy Lipid Metabolism Disorders, Metachromatic Leukodystrophy (MLD), Nervous System Diseases | — | 2015-11-02 |
| Completed | Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for th Hereditary Angioedema (HAE) | Phase 3 | 2015-11-01 |
| Completed | Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age Hunter Syndrome | Phase 4 | 2015-10-28 |
| Completed | Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD Attention Deficit Hyperactivity Disorder (ADHD) | Phase 1 | 2015-10-24 |
| Completed | A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARA Hypoparathyroidism | — | 2015-09-01 |
| Completed | Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit Attention Deficit Hyperactivity Disorder (ADHD) | Phase 3 | 2015-08-21 |
| Completed | Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperac Attention Deficit Hyperactivity Disorder (ADHD) | Phase 3 | 2015-06-18 |
| Completed | Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-defic Attention Deficit Hyperactivity Disorder (ADHD) | Phase 2 | 2015-04-15 |
| Completed | Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Particip Hunter Syndrome | Phase 2 / Phase 3 | 2015-04-14 |
| Terminated | An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Part Sanfilippo Syndrome, Mucopolysaccharidosis (MPS) | Phase 2 | 2015-04-08 |
| Completed | Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for t Retinopathy of Prematurity (ROP) | Phase 2 | 2015-03-26 |
| Completed | A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants Hereditary Angioedema (HAE) | Phase 3 | 2015-03-18 |
| Completed | Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-depend Short Bowel Syndrome | Phase 3 | 2014-12-18 |
| Completed | Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Coliti Ulcerative Colitis | Phase 3 | 2014-12-12 |
| Withdrawn | Treatment of Iron Overload Requiring Chelation Therapy Transfusional Iron Overload, Iron Overload, Iron Chelation | Phase 2 | 2014-11-20 |
| Completed | A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3) Dry Eye Disease | Phase 3 | 2014-11-06 |
| Completed | A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominan Autosomal Dominant Hypocalcemia (ADH) | Phase 2 | 2014-07-18 |
| Completed | Short Term Observational Study in DEB Patients Dystrophic Epidermolysis Bullosa | — | 2014-06-24 |
| Active Not Recruiting | Registry for Participants With Short Bowel Syndrome Short Bowel Syndrome | — | 2014-06-23 |
| Completed | Taste Assessment Study of SHP429 in Healthy Adult Subjects Healthy | Phase 1 | 2014-06-02 |
| Terminated | Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Mucopolysaccharidosis (MPS) | — | 2014-05-21 |
| Completed | A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 i Hereditary Angioedema (HAE) | Phase 1 | 2014-05-14 |
| Completed | Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunt Hunter Syndrome | Phase 2 / Phase 3 | 2014-03-24 |
| Completed | Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditar Hereditary Angioedema (HAE) | Phase 3 | 2014-03-20 |
| Withdrawn | Pharmacokinetics of Granule and Tablet Formulations of Deferitazole (Disodium Salt) and a Capsule Formulation Healthy | Phase 1 | 2014-02-28 |
| Completed | Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD Sanfilippo Syndrome | Phase 2 | 2014-02-26 |
| Completed | Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Hereditary Angioedema (HAE) | Phase 1 | 2014-02-21 |
| Completed | Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Binge Eating Disorder | Phase 3 | 2014-01-27 |
| Completed | Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor In Angiotensin Converting Enzyme Inhibitor Induced Angioedema | Phase 3 | 2013-12-02 |
| Completed | Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects Healthy | Phase 1 | 2013-11-26 |
| Completed | Effect of SSP-004184 (SPD602) on the Pharmacokinetics of Simvastatin in Healthy Adult Subjects Healthy | Phase 1 | 2013-11-18 |
| Completed | A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syn Short Bowel Syndrome | Phase 3 | 2013-11-14 |
| Completed | The Effect of Food on the Bioavailability of a Single Dose of SSP-004184SS in Healthy Adult Subjects Healthy | Phase 1 | 2013-08-27 |
| Completed | Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia Friedreich's Ataxia | Phase 1 | 2013-08-13 |
| Completed | A Single Increasing Dose Study to Assess Safety and Tolerability of DX-2930 in Healthy Subjects Hereditary Angioedema (HAE) | Phase 1 | 2013-08-12 |
| Completed | A Relative Bioavailability Study of SSP-004184AQ (Magnesium Salt) and SSP-004184SS (Disodium Salt) Healthy | Phase 1 | 2013-08-05 |
| Completed | Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volun Healthy Volunteers | Phase 1 | 2013-07-15 |
| Active Not Recruiting | An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy Metachromatic Leukodystrophy (MLD) | Phase 1 / Phase 2 | 2013-05-23 |
| Completed | FST-100 in the Treatment of Acute Viral Conjunctivitis Acute Viral Conjunctivitis | Phase 2 | 2013-05-17 |
| Completed | AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184 Healthy | Phase 1 | 2013-05-01 |
| Terminated | An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Placement of an Arteriovenous G Arteriovenous Graft | Phase 2 | 2013-03-28 |
| Completed | An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fi Arteriovenous Fistula | Phase 2 | 2013-03-26 |
| Completed | Long-Term Safety Of PF-00547659 In Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2013-03-18 |
| Completed | Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled Prucalopride Succinate in Volunteers Healthy | Phase 1 | 2013-03-18 |
| Completed | Multicenter Extension Study of Velaglucerase Alfa in Japanese Patients With Gaucher Disease Gaucher Disease | Phase 3 | 2013-03-13 |
| Completed | Adsorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled SPD557 in Volunteers Healthy Volunteers | Phase 1 | 2013-03-07 |
| Completed | Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity Chronic Constipation | Phase 4 | 2013-02-27 |
| Completed | A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety an Chronic Kidney Disease, Hyperphosphatemia | Phase 2 | 2013-02-15 |
| Completed | Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks Hereditary Angioedema (HAE) | Phase 2 | 2013-02-04 |
| Terminated | Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults Schizophrenia | Phase 3 | 2013-02-01 |
| Terminated | SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Sta Schizophrenia | Phase 3 | 2013-02-01 |
| Completed | Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II) Mucopolysaccharidosis (MPS), Hunter Syndrome | — | 2013-01-18 |
| Completed | FST-100 in the Treatment of Acute Adenoviral Conjunctivitis Acute Adenoviral Conjunctivitis | Phase 2 | 2012-12-17 |
| Completed | A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye Dry Eye Disease | Phase 3 | 2012-12-07 |
| Completed | SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder Binge Eating Disorder | Phase 3 | 2012-11-26 |
| Completed | SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder Binge Eating Disorder | Phase 3 | 2012-11-26 |
| Completed | Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome Hunter Syndrome | — | 2012-11-12 |
| Completed | Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver Function Hepatic Impairment, Healthy | Phase 1 | 2012-11-09 |
| Completed | A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2012-11-02 |
| Terminated | Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Schizophrenia | Phase 3 | 2012-11-01 |
| Completed | Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Funct Impaired Renal Function | Phase 1 | 2012-10-29 |
| Completed | Safety Study of Lifitegrast to Treat Dry Eye Dry Eye Disease | Phase 3 | 2012-10-16 |
| Completed | Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease Gaucher Disease, Type 3 | Phase 1 / Phase 2 | 2012-09-14 |
| Terminated | Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy Iron Overload Due to Repeated Red Blood Cell Transfusions | Phase 2 | 2012-09-14 |
| Completed | Open Label Extension in Adults With Binge Eating Disorder (BED) Binge Eating Disorder | Phase 3 | 2012-08-21 |
| Terminated | Study for Transfusionally Iron Overloaded Children, Adolescents and Adults Using FBS0701 (SSP-004184) Iron Overload Due to Repeated Red Blood Cell Transfusions | Phase 2 | 2012-08-14 |
| Terminated | A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (A Chronic Adrenal Insufficiency | — | 2012-08-07 |
| Completed | OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Eosinophilic Esophagitis (EoE) | Phase 2 | 2012-07-23 |
| Completed | Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients Cytomegalovirus (CMV) | Phase 2 | 2012-07-17 |
| Withdrawn | Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema Hereditary Angioedema (HAE) | Phase 2 / Phase 3 | 2012-06-01 |
| Completed | Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension Symptomatic Orthostatic Hypotension | Phase 4 | 2012-05-23 |
| Completed | A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021 Short Bowel Syndrome | Phase 3 | 2012-05-21 |
| Completed | Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension Orthostatic Hypotension | Phase 4 | 2012-05-14 |
| Completed | A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema Hereditary Angioedema (HAE) | — | 2012-05-11 |
| Completed | Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colit Crohn's Disease, Ileitis, Ileo-colonic and Colonic Crohn's Disease | Phase 1 | 2012-05-03 |
| Completed | Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder Attention-deficit/Hyperactivity Disorder | Phase 4 | 2012-04-17 |
| Completed | Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B) Sanfilippo Syndrome Type B | — | 2012-04-09 |
| Completed | Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder Attention-deficit/Hyperactivity Disorder | Phase 4 | 2012-04-03 |
| Completed | Effect of Anagrelide Hydrochloride on Any Changes in Heart Function in Healthy Volunteers Healthy | Phase 1 | 2012-03-29 |
| Completed | Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Attention Deficit Hyperactivity Disorder (ADHD) | Phase 3 | 2012-03-20 |
| Completed | Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease Gaucher Disease | Phase 3 | 2012-03-02 |
| Terminated | SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study Major Depressive Disorder | Phase 3 | 2012-02-27 |
| Completed | Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Dise Gastroesophageal Reflux Disease | Phase 2 | 2012-02-27 |
| Completed | Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD) Metachromatic Leukodystrophy (MLD) | Phase 1 / Phase 2 | 2012-02-02 |
| Withdrawn | SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia Negative Symptoms of Schizophrenia | Phase 3 | 2012-01-27 |
| Completed | A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angi Hereditary Angioedema (HAE) | Phase 3 | 2012-01-27 |
| Completed | SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), Generalized Anxiety Disorder (GAD), Anxiety, Separation, Phobia, Social | Phase 2 | 2012-01-04 |
| Completed | This Study is Designed to Evaluate PD/PK and Safety of Replagal Manufactured by Two Different Processes. Fabry Disease | Phase 2 | 2011-11-17 |
| Completed | Sulfamethoxazole Drug Interaction Study With MMX® Mesalazine/Mesalamine Healthy | Phase 1 | 2011-11-07 |
| Completed | Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Majo Major Depressive Disorder | Phase 3 | 2011-10-27 |
| Completed | Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophreni Schizophrenia | Phase 1 | 2011-10-21 |
| Completed | Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Majo Major Depressive Disorder | Phase 3 | 2011-10-19 |
| Completed | Amoxicillin Drug Interaction Study With MMX® Mesalazine/Mesalamine Healthy | Phase 1 | 2011-10-07 |
| Completed | Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Usi Attention-Deficit/Hyperactivity Disorder | Phase 3 | 2011-09-19 |
| Completed | A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Hum Hereditary Angioedema | Phase 2 | 2011-09-12 |
| Completed | Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OP Keratoconjunctivitis Sicca, Dry Eye Disease | Phase 3 | 2011-08-29 |
| Completed | A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Re Graft Rejection | Phase 2 | 2011-08-24 |
| Completed | Metronidazole Drug Interaction Study With MMX® Mesalazine/Mesalamine Healthy | Phase 1 | 2011-08-22 |
| Completed | A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroi Hypoparathyroidism | Phase 3 | 2011-08-19 |
| Completed | SSP-002358 Drug Interaction Study With Omeprazole Healthy | Phase 1 | 2011-08-11 |
| Terminated | Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iro Transfusional Iron Overload, Beta-Thalassemia | Phase 2 | 2011-08-10 |
| Completed | A Multicenter Open-Label Treatment Protocol to Observe the Safety of Replagal (Agalsidase Alfa) Enzyme Replace Fabry Disease | Phase 3 | 2011-08-10 |
| Completed | Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine Healthy | Phase 1 | 2011-07-25 |
| Completed | Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID® Essential Thrombocythemia (ET) | — | 2011-07-19 |
| Completed | Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivi Attention Deficit Hyperactivity Disorder (ADHD) | Phase 4 | 2011-07-07 |
| Completed | A Study To Monitor Long-Term Treatment With PF-00547659 Crohn's Disease | Phase 2 | 2011-07-01 |
| Completed | Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection Clostridium Difficile Infection | Phase 2 | 2011-06-27 |
| Terminated | Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema ACE Inhibitor Induced Angioedema | Phase 2 | 2011-06-01 |
| Completed | SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder Major Depressive Disorder | Phase 2 | 2011-05-31 |
| Completed | Home Therapy With VPRIV in Gaucher's Disease Gaucher Disease | — | 2011-05-20 |
| Completed | Safety Study of Replagal® Therapy in Children With Fabry Disease Fabry Disease | Phase 2 | 2011-05-12 |
| Completed | Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder Binge Eating Disorder | Phase 2 | 2011-05-10 |
| Completed | Prucalopride in Pediatric Subjects With Functional Constipation Functional Constipation | Phase 3 | 2011-04-28 |
| Completed | Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease Crohn's Disease | Phase 2 | 2011-04-06 |
| Completed | A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormo Hypoparathyroidism | Phase 3 | 2011-04-06 |
| Completed | Evaluation of Long-term Prucalopride Treatment With Chronic Constipation in Subjects Aged ≥ 18 Years Constipation | Phase 4 | 2011-04-06 |
| Completed | Home Therapy With Replagal in Fabry Disease Fabry Disease | — | 2011-03-15 |
| Withdrawn | Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Dis ADHD | Phase 3 | 2011-03-06 |
| Terminated | Extension of Study HGT-SAN-055 Evaluating Administration of rhHNS in Patients With Sanfilippo Syndrome Type A Sanfilippo Syndrome | Phase 1 / Phase 2 | 2011-03-01 |
| Completed | Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidis Hypoparathyroidism | Phase 3 | 2011-02-09 |
| Completed | Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years W Attention Deficit Hyperactivity Disorder | Phase 3 | 2011-01-17 |
| Completed | Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD Chronic Kidney Disease | Phase 2 | 2010-12-06 |
| Terminated | An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Gastroesophageal Reflux Disease | Phase 2 | 2010-12-02 |
| Completed | Sophisticated Assessment of Disease Burden in Patients With Fabry Disease Fabry Disease | — | 2010-10-31 |
| Completed | Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy Volunteers Healthy | Phase 1 | 2010-10-28 |
| Completed | Effect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential Thrombocythaemia Essential Thrombocythemia (ET) | Phase 3 | 2010-10-27 |
| Completed | Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia Essential Thrombocythemia (ET) | Phase 3 | 2010-10-27 |
| Completed | Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis Ulcerative Colitis | Phase 1 | 2010-10-08 |
| Completed | Pediatric Disease Registry in Essential Thrombocythaemia (ET) Essential Thrombocythemia (ET) | — | 2010-09-28 |
| Completed | Effect of Teduglutide on Gastric Emptying in Healthy Subjects Healthy Volunteers | Phase 1 | 2010-09-28 |
| Completed | Evaluation of Prucalopride in Male Subjects With Chronic Constipation. Male Subjects With Chronic Constipation | Phase 3 | 2010-09-23 |
| Completed | French Observational Xagrid (FOX) Study In Adult Patients With Essential Thrombocythemia Essential Thrombocythemia | — | 2010-09-13 |
| Completed | SPD544 High Strength Bioequivalence Study ADHD | Phase 1 | 2010-08-27 |
| Completed | Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload Transfusional Iron Overload, Beta-thalassemia | Phase 2 | 2010-08-13 |
| Recruiting | Gaucher Disease Outcome Survey (GOS) Gaucher Disease | — | 2010-07-27 |
| Completed | Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis | Phase 4 | 2010-06-29 |
| Completed | Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (AD Attention-Deficit/Hyperactivity Disorder | Phase 3 | 2010-06-28 |
| Completed | IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity Retinopathy of Prematurity (ROP) | Phase 2 | 2010-06-18 |
| Completed | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration Hereditary Angioedema | Phase 2 | 2010-06-07 |
| Completed | CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12 Hereditary Angioedema (HAE) | Phase 2 | 2010-06-02 |
| Completed | Safety, Tolerability, Ascending Dose and Dose Frequency Study of rhHNS Via an IDDD in MPS IIIA Patients Mucopolysaccharidosis (MPS) | Phase 1 / Phase 2 | 2010-06-01 |
| Terminated | Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation Non-cancer Pain, Opioid Induced Constipation | Phase 3 | 2010-05-19 |
| Completed | Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity D ADHD Specifically With Executive Function Impairment | Phase 4 | 2010-05-19 |
| Completed | Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/ Attention-deficit/Hyperactivity Disorder | Phase 3 | 2010-05-11 |
| Completed | Study of PVS-10200 for the Treatment of Restenosis in Patients With Peripheral Artery Disease (TRIUMPH) Peripheral Artery Disease | Phase 1 / Phase 2 | 2010-04-30 |
| Completed | Effect of Lanthanum Carbonate in Patients Previously Treated With Calcium-based Phosphate Binder Therapy End Stage Renal Disease | — | 2010-04-26 |
| Completed | Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry Di Fabry Disease | Phase 3 | 2010-04-13 |
| Completed | Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss Sleep Deprivation | Phase 2 | 2010-04-05 |
| Withdrawn | An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD) Leukodystrophy, Globoid Cell | — | 2010-04-01 |
| Completed | A Study of Patients With Sanfilippo Syndrome Type A (MPS IIIA) Sanfilippo Syndrome Type A | — | 2010-02-15 |
| Completed | Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioede Hereditary Angioedema (HAE) | — | 2010-02-01 |
| Completed | Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of T Attention-Deficit Hyperactivity Disorder | Phase 1 | 2010-01-05 |
| Completed | A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery D Hunter Syndrome | Phase 1 / Phase 2 | 2009-11-18 |
| Completed | Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Chi Attention-Deficit/Hyperactivity Disorder | Phase 3 | 2009-11-17 |
| Completed | SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurre Major Depressive Disorder | Phase 2 | 2009-10-29 |
| Completed | EASSI - Evaluation of the Safety of Self-Administration With Icatibant Hereditary Angioedema | Phase 3 | 2009-09-25 |
| Completed | Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS) Short Bowel Syndrome | Phase 3 | 2009-09-21 |
| Completed | Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms Schizophrenia and Predominant Negative Symptoms | Phase 2 | 2009-09-14 |
| Completed | FST-201 in the Treatment of Acute Otitis Externa Acute Otitis Externa | Phase 3 | 2009-08-31 |
| Completed | A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE Hereditary Angioedema | Phase 4 | 2009-08-31 |
| Completed | A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Co Dry Eye | Phase 2 | 2009-08-03 |
| Terminated | FST-201 In The Treatment of Acute Fungal Otitis Externa Acute Fungal Otitis Externa | Phase 3 | 2009-07-31 |
| Terminated | FST-201 In The Treatment of Acute Otitis Externa Acute Otitis Externa | Phase 3 | 2009-07-31 |
| Completed | Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antid Major Depressive Disorder | Phase 2 | 2009-07-30 |
| Completed | A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3) Hereditary Angioedema | Phase 3 | 2009-07-16 |
| Completed | Firazyr® Patient Registry (Icatibant Outcome Survey - IOS) Hereditary Angioedema (HAE) | — | 2009-07-10 |
| Completed | Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervou Hunter Syndrome | — | 2009-07-02 |
| Terminated | FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis Acute Adenoviral Conjunctivitis | Phase 2 | 2009-06-30 |
| Completed | A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy Volunte Healthy | Phase 1 | 2009-06-24 |
| Completed | The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Health Healthy | Phase 1 | 2009-06-01 |
| Completed | A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunt Healthy | Phase 1 | 2009-05-18 |
| Completed | Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder Attention-Deficit/Hyperactivity Disorder | Phase 4 | 2009-04-30 |
| Completed | Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis Allergic Conjunctivitis | Phase 2 | 2009-04-24 |
| Completed | Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteer Kidney Failure, Chronic | Phase 1 | 2009-04-20 |
| Completed | Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults End Stage Renal Disease | Phase 1 | 2009-01-28 |
| Completed | Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Childr ADHD | Phase 3 | 2009-01-27 |
| Completed | Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis Eosinophilic Esophagitis (EoE) | Phase 2 | 2009-01-08 |
| Completed | Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease Fabry Disease | Phase 3 | 2008-12-29 |
| Completed | Use of NPSP558 in the Treatment of Hypoparathyroidism Hypoparathyroidism | Phase 3 | 2008-12-18 |
| Completed | Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects Short Bowel Syndrome | Phase 3 | 2008-11-25 |
| Terminated | Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral So Healthy | Phase 1 | 2008-11-21 |
| Completed | Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adoles ADHD | Phase 3 | 2008-11-17 |
| Completed | Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study ADHD | Phase 3 | 2008-11-13 |
| Completed | An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients Hunter Syndrome | — | 2008-10-14 |
| Completed | Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity D Attention Deficit Hyperactivity Disorder (ADHD) | Phase 3 | 2008-10-08 |
| Completed | Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Healthy Volunteers | Phase 1 | 2008-09-08 |
| Completed | Efficacy and Safety of SPD503 in Combination With Psychostimulants ADHD | Phase 3 | 2008-09-02 |
| Completed | Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention- ADHD | Phase 3 | 2008-07-18 |
| Terminated | DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment) Anemia, Kidney Diseases, Renal Failure, Chronic | — | 2008-04-25 |
| Completed | Guanfacine Immediate-release Electrocardiogram Results (QTc) Study Healthy Volunteers | Phase 1 | 2008-04-18 |
| Completed | An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease Gaucher Disease, Type 1 | Phase 3 | 2008-03-13 |
| Terminated | Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLD Late Infantile Metachromatic Leukodystrophy | Phase 2 | 2008-02-20 |
| Completed | Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Di Gaucher Disease, Type 1 | Phase 3 | 2008-01-29 |
| Completed | Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Ther Hunter Syndrome, Mucopolysaccharidosis II, MPS II | Phase 4 | 2007-12-31 |
| Completed | Prevention of Recurrence of Diverticulitis Diverticulitis | Phase 3 | 2007-12-06 |
| Completed | Prevention of Recurrence of Diverticulitis Diverticulitis | Phase 3 | 2007-11-28 |
| Completed | Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency Adrenal Insufficiency | Phase 2 / Phase 3 | 2007-08-21 |
| Completed | Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared Hepatic Impairment | Phase 1 | 2007-07-26 |
| Completed | Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imigluce Gaucher Disease | Phase 2 / Phase 3 | 2007-07-25 |
| Completed | Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Reci Cytomegalovirus Infections | Phase 3 | 2007-07-23 |
| Completed | Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesyla Attention Deficit Hyperactivity Disorder (ADHD) | Phase 4 | 2007-06-28 |
| Completed | A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects A ADHD | Phase 3 | 2007-06-13 |
| Terminated | Dynepo Long-Term Safety Study Anemia, Kidney Failure, Chronic | Phase 4 | 2007-06-06 |
| Terminated | Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Kidney Diseases | Phase 4 | 2007-05-22 |
| Completed | Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix Syste Ulcerative Colitis | Phase 4 | 2007-05-01 |
| Withdrawn | A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Si Attention Deficit Hyperactivity Disorder | Phase 3 | 2007-04-30 |
| Completed | Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema ( Hereditary Angioedema (HAE) | Phase 3 | 2007-04-01 |
| Completed | Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE) Hereditary Angioedema (HAE) | Phase 3 | 2007-04-01 |
| Completed | Long-term Effect of Lanthanum Carbonate on Bone Hyperphosphatemia | — | 2007-03-15 |
| Completed | A Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Gaucher Disease Gaucher Disease, Type 1 | Phase 3 | 2007-02-15 |
| Completed | Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers Leg Ulcer, Varicose Ulcer | Phase 1 / Phase 2 | 2007-01-31 |
| Completed | Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD) Late Infantile Metachromatic Leukodystrophy | Phase 1 / Phase 2 | 2007-01-22 |
| Completed | Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD) Metachromatic Leukodystrophy (MLD) | Phase 1 | 2007-01-22 |
| Completed | Head to Head Study Against Sevelamer Hydrochloride Chronic Kidney Disease, Stage 5 | Phase 3 | 2007-01-05 |
| Completed | Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Reci Cytomegalovirus Infections | Phase 3 | 2006-12-13 |
| Completed | SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms ADHD | Phase 3 | 2006-12-04 |
| Completed | The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET) Essential Thrombocythaemia | Phase 2 | 2006-11-13 |
| Terminated | Dynepo Infrequent Dosing Study Anemia, Kidney Failure | Phase 3 | 2006-10-30 |
| Completed | Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects Hereditary Angioedema | Phase 1 | 2006-10-09 |
| Completed | Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks Hereditary Angioedema | Phase 3 | 2006-09-21 |
| Completed | A Double-Blind Multi-Dose Tolerability and Pharmacokinetic Study of Teduglutide Pharmacokinetics and Safety of Elevated Doses | Phase 1 | 2006-09-06 |
| Completed | Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks Hereditary Angioedema | Phase 3 | 2006-06-27 |
| Completed | Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol) Hyperphosphatemia | — | 2006-04-25 |
| Completed | A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients Thrombocythemia, Hemorrhagic | Phase 4 | 2006-01-13 |
| Completed | Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Kidney Diseases | Phase 2 | 2006-01-11 |
| Completed | Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE) Hereditary Angioedema (HAE) | Phase 3 | 2005-12-31 |
| Completed | Hunter Outcome Survey (HOS) Hunter Syndrome | — | 2005-10-03 |
| Completed | Safety and Efficacy of SPD465 in Adults With ADHD Attention Deficit Disorder With Hyperactivity | Phase 2 | 2005-09-29 |
| Completed | Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compar Thrombocythemia, Essential | — | 2005-05-31 |
| Completed | Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 Attention Deficit Disorder With Hyperactivity | Phase 2 | 2005-05-12 |
| Completed | Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD. Attention Deficit Disorder With Hyperactivity | Phase 3 | 2005-04-25 |
| Completed | Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis Ulcerative Colitis | Phase 3 | 2005-04-08 |
| Completed | C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks Hereditary Angioedema | Phase 3 | 2005-03-14 |
| Completed | C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks Hereditary Angioedema | Phase 3 | 2005-03-14 |
| Completed | Safety of SPD465 in Treating Adults With ADHD. Attention Deficit Disorder With Hyperactivity | Phase 3 | 2005-03-10 |
| Completed | Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE) Hereditary Angioedema | Phase 3 | 2005-03-01 |
| Completed | Efficacy and Safety of SPD465 in Adults With ADHD Attention Deficit Disorder With Hyperactivity | Phase 3 | 2005-01-27 |
| Completed | Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Dis Kidney Failure, Chronic | Phase 4 | 2005-01-10 |
| Completed | Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-0 Short Bowel Syndrome | Phase 3 | 2005-01-10 |
| Completed | Open Label Extension Osteoporosis | Phase 3 | 2005-01-10 |
| Completed | Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for Kidney Failure, Chronic | Phase 3 | 2005-01-07 |
| Completed | Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema Angioedema | Phase 3 | 2004-12-28 |
| Completed | Maribavir for Prevention of CMV After Stem Cell Transplants Cytomegalovirus Infection | Phase 2 | 2004-10-28 |
| Completed | Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idurs Hunter Syndrome, Mucopolysaccharidosis II (MPS II) | Phase 2 / Phase 3 | 2004-09-13 |
| Completed | Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX00 Gaucher Disease | Phase 1 / Phase 2 | 2004-09-13 |
| Completed | Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension Hypotension, Orthostatic | Phase 4 | 2004-09-08 |
| Completed | Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-De Attention Deficit Disorder With Hyperactivity | Phase 2 | 2004-08-16 |
| Completed | The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD) Attention-Deficit/Hyperactivity Disorder | Phase 2 | 2004-06-14 |
| Completed | Replagal Enzyme Replacement Therapy for Children With Fabry Disease Fabry Disease | Phase 2 | 2004-06-10 |
| Completed | Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Short Bowel Syndrome | Phase 3 | 2004-05-25 |
| Completed | Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Recei Kidney Failure, Chronic | Phase 3 | 2004-05-11 |
| Completed | Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 Attention Deficit Disorder With Hyperactivity | Phase 3 | 2004-03-30 |
| Completed | Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008 Crohn's Disease | Phase 2 | 2004-03-01 |
| Completed | ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared t Attention Deficit Disorder With Hyperactivity | Phase 3 | 2004-02-25 |
| Completed | Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Diseas Kidney Failure, Chronic | Phase 3 | 2004-02-09 |
| Completed | Calcium Supplementation in Postmenopausal Women Osteoporosis | Phase 3 | 2004-01-10 |
| Completed | Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches Migraine Headache | Phase 2 | 2003-12-31 |
| Completed | Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8 Ulcerative Colitis | Phase 3 | 2003-12-04 |
| Completed | Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis. Colitis, Ulcerative | Phase 3 | 2003-11-26 |
| Completed | Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Crohn's Disease | Phase 2 | 2003-11-12 |
| Completed | EDEMA2: Evaluation of DX-88's Effect in Mitigating Angioedema Hereditary Angioedema (HAE) | Phase 2 | 2003-11-01 |
| Completed | Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 Colitis, Ulcerative | Phase 3 | 2003-09-30 |
| Completed | Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II) Mucopolysaccharidosis II | Phase 2 / Phase 3 | 2003-09-18 |
| Completed | Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD ADHD | Phase 4 | 2003-08-05 |
| Completed | Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperacti ADHD | Phase 3 | 2003-05-28 |
| Completed | Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476 Colitis, Ulcerative | Phase 2 | 2003-02-10 |
| Completed | Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-1 Attention Deficit Disorder With Hyperactivity | Phase 3 | 2003-01-29 |
| Completed | A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in P Kidney Failure, Chronic | Phase 3 | 2002-10-14 |
| Terminated | A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension Hypotension, Orthostatic | Phase 4 | 2002-09-05 |
| Completed | Open Label Extension Study of PREOS Osteoporosis | Phase 3 | 2001-10-16 |
| Completed | Fabry Outcome Survey (FOS) Fabry Disease | — | 2001-04-01 |
| Completed | Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia Leukemia | Phase 2 | 2000-12-11 |
| Completed | TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteop Osteoporosis | Phase 3 | 2000-04-27 |
| Completed | A Study for Patients With Neurogenic Orthostatic Hypotension Hypotension, Orthostatic | Phase 4 | 1997-12-01 |
| Completed | A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postme Osteoporosis | Phase 2 | 1995-05-18 |
| No Longer Available | Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-h Hereditary Angioedema (HAE), Angioedema | — | — |
| Approved For Marketing | Treatment Protocol of Velaglucerase Alfa for Patients With Type 1 Gaucher Disease Gaucher Disease, Type 1 | — | — |
| No Longer Available | Treatment Protocol of Replagal for Patients With Fabry Disease Fabry Disease | — | — |